202 related articles for article (PubMed ID: 37290818)
21. 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
Sommerauer M; Burkhardt JK; Frontzek K; Rushing E; Buck A; Krayenbuehl N; Weller M; Schaefer N; Kuhn FP
Neuro Oncol; 2016 Jul; 18(7):1021-7. PubMed ID: 26865086
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of [
Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
[TBL] [Abstract][Full Text] [Related]
23. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.
Kurz SC; Zan E; Cordova C; Troxel AB; Barbaro M; Silverman JS; Snuderl M; Zagzag D; Kondziolka D; Golfinos JG; Chi AS; Sulman EP
Clin Cancer Res; 2024 Feb; 30(4):680-686. PubMed ID: 38048045
[TBL] [Abstract][Full Text] [Related]
25. 68 Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis.
Hartmann K; Gillman JA; Lazor JW; Ware JB; Weeks JK; Nasrallah IM; Farwell MD; Pantel AR
Clin Nucl Med; 2024 Jan; 49(1):9-15. PubMed ID: 38048554
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin receptor-positive granulomatous inflammation mimicking as meningioma on simultaneous PET/MRI.
Taneja S; Jena A; Kaul S; Jha A; Sogani SK
Clin Nucl Med; 2015 Jan; 40(1):e71-2. PubMed ID: 24662657
[TBL] [Abstract][Full Text] [Related]
27. The usefulness of [
Wang P; Liu S; Li X; Liu X; Li S; Wu Z; Cheng X
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):218-225. PubMed ID: 37682301
[TBL] [Abstract][Full Text] [Related]
28. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
[TBL] [Abstract][Full Text] [Related]
29. Complementary Molecular and Metabolic Characterization of Meningiomas With DOTATATE and FDG-PET: Advancing Treatment Planning and Prognostication.
Dressen MS; Muthukrishnan A; Tragon TR; Lieberman FS; Mountz JM
Clin Nucl Med; 2019 Jan; 44(1):e26-e27. PubMed ID: 30371576
[TBL] [Abstract][Full Text] [Related]
30. [(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.
Vrachimis A; Stegger L; Wenning C; Noto B; Burg MC; Konnert JR; Allkemper T; Heindel W; Riemann B; Schäfers M; Weckesser M
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1765-72. PubMed ID: 27059853
[TBL] [Abstract][Full Text] [Related]
31. 68 Ga-FAPI04 Versus 68 Ga-DOTATATE PET/CT in a Patient With Multiple Meningioma.
Denizmen D; Isik EG; Buyukkaya F; Kuyumcu S
Clin Nucl Med; 2023 May; 48(5):e244-e245. PubMed ID: 36881633
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hitherto unknown brain meningioma detected on
Parghane RV; Talole S; Basu S
World J Nucl Med; 2019; 18(2):160-170. PubMed ID: 31040748
[TBL] [Abstract][Full Text] [Related]
33. Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma.
Müther M; Roll W; Brokinkel B; Zinnhardt B; Sporns PB; Seifert R; Schäfers M; Weckesser M; Stegger L; Stummer W; Rahbar K
Nuklearmedizin; 2020 Sep; 59(5):348-355. PubMed ID: 32691404
[TBL] [Abstract][Full Text] [Related]
34. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
35. Postoperative [
Teske N; Biczok A; Quach S; Dekorsy FJ; Forbrig R; Bodensohn R; Niyazi M; Tonn JC; Albert NL; Schichor C; Ueberschaer M
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):206-217. PubMed ID: 37642702
[TBL] [Abstract][Full Text] [Related]
36. 68Ga-DOTA-peptide PET/CT for radiotherapy planning and evaluating treatment response in the management of meningiomas.
Usmani S; Jain A; Hashmi SF; Mula-Hussain L; Riyami KA; Abubakar S; Shamim MS
J Pak Med Assoc; 2023 Jun; 73(6):1340-1343. PubMed ID: 37427649
[TBL] [Abstract][Full Text] [Related]
37.
AlSadi R; Maaz AUR; Bouhali O; Djekidel M
J Nucl Med Technol; 2023 Jun; 51(2):140-146. PubMed ID: 37192823
[No Abstract] [Full Text] [Related]
38. Meningiomas: a comparative study of 68Ga-DOTATOC, 68Ga-DOTANOC and 68Ga-DOTATATE for molecular imaging in mice.
Soto-Montenegro ML; Peña-Zalbidea S; Mateos-Pérez JM; Oteo M; Romero E; Morcillo MÁ; Desco M
PLoS One; 2014; 9(11):e111624. PubMed ID: 25369268
[TBL] [Abstract][Full Text] [Related]
39. Superiority of
Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
[TBL] [Abstract][Full Text] [Related]
40. Utility of 68Ga-DOTATATE PET-MRI for Gamma Knife® stereotactic radiosurgery treatment planning for meningioma.
Ratnayake G; Huo M; Mehta A; Ramachandran P; Pinkham MB; Law P; Watkins T; Olson S; Hall B; Brown S; Lusk R; Jones C; O'Mahoney E; McGill G; Foote MC
Br J Radiol; 2024 Jan; 97(1153):180-185. PubMed ID: 38263827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
